Purification of G4 Resolvase1 : a protein entangled in many cellular functions by Beerbower, Peter Edward
THE PURIFICATION OF G4 RESOLVASE1: 
A PROTEIN ENTANGLED IN MANY CELLULAR FUNCTIONS 
AN HONORS THESIS (HONORS 499) 
BY 
PETER EDWARD BEERBOWER 
THESIS ADVISOR 
DR. PHILIP J. SMALDINO 
BALL STATE UNIVERSITY 
MUNCIE, INDIANA 
MAY 2018 
EXPECTED DATE OF GRADUATION 
MAY 2018 
ABSTRACT 
G-quadruplexes are supersecondary structures that form in guanine-rich 
regions of DNA and RNA. These structures are extremely thermally stable, likely 
to form in -750,000 locations in the human genome and are enriched in the 
promoter regions of proto-oncogenes and developmental genes, non-coding 
regions, and within telomeres. Due to the prevalence of these structures in key 
genomic locations, these structures are cable of regulating a large fraction of 
cellular processes. Within humans, the enzyme G4 Resolvase 1 (G4R1) is 
responsible for the majority of G-quadruplex resolving activity. This places G4R1 
at the forefront of regulating all functions involved with G-quadruplexes. Despite 
regulating G-quadruplexes, a nearly ubiquitous structure throughout the human 
genome, G4R1 is relatively understudied. Within this thesis, I present a method 
for producing highly pure and selectively catalytically active samples of rG4R1 
and discuss the potential involvement of G4R1 with the pathology of Amyotrophic 
Lateral Sclerosis. 
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research scientist. 
While writing this thesis, I have greatly improved my ability to analyze 
current scientific literature and search available biological databases for relevant 
information. These skills have proven invaluable for proposing future research in 
grants, papers, and in discussions with other scientists. 
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CHAPTER ONE 
Purification of Catalytically Active G4 Resolvase1 
1.1 Introduction 
G-Quadruplexes are highly stable nucleic acid supersecondary structures 
that form within guanine-rich regions of DNA and RNA. These structures are 
stabilized by Hoogsteen-bonding interactions, coordinate bonding within the 
central cavity with monovalent cations, and Van der Waals forces that confer 
extreme thermal stability to G-quadruplexes (QIN AND HURLEY 2008; STEGLE eta/. 
2009). Recent bioinformatics analysis predicts that there are -750,000 locations 
in the human genome likely to form G-quadruplexes (BEDRAT eta/. 2016). G-
Quadruplex forming sequences are not randomly distributed, but evolutionarily 
conserved and enriched within transcribed regions. Upwards of 40% of human 
gene promoters containing G-Quadruplex forming motifs (HUPPERT AND 
BALASUBRAMANIAN 2007). Genes with related functions have been found to have 
similar degrees of enrichment, with proto-oncogenes and developmental genes 
having significantly greater G-quadruplex motif enrichment than tumor 
suppressor genes (EDDY AND MAIZELS 2006; EDDY eta/. 2011 ). 
With extreme thermal stability, prevalence throughout the human genome, 
and the ability to affect major regulatory pathways, it is not surprising that there is 
1 
an enzymatic mechanism for regulating G-quadruplexes. The enzyme 
responsible for the majority of G-quadruplex resolving activity in human cells is 
G4 Resolvase1 (G4R1; alias RHAU and DHX36) (VAUGHN eta/. 2005). This 
protein has been found to unwind both tetramolecular and unimolecular G-
Quadruplexes in DNA and RNA, while also having the highest reported binding 
affinity for all know G-Quadruplex binding proteins (CREACY eta/. 2008; GIRl eta/. 
2011; Booy eta/. 2012). The G-Quadruplex resolving activity of G4R1 has been 
found to be involved in many cellular processes, including telomere biology, 
transcription and splicing regulation, development, lineage commitment, immune 
regulation, and the localization of cellular machinery (TRAN eta/. 2004; KIM eta/. 
201 0; LATTMANN eta/. 2011; SEXTON AND COLLINS 2011; ZHANG eta/. 2011; BOOY 
eta/. 2012; HUANG eta/. 2012; LAI eta/. 2012; BICKER eta/. 2013; BOOY eta/. 
2014; Yoo eta/. 2014; SMALDINO eta/. 2015; JING eta/. 2017; NEWMAN eta/. 
2017). 
Here, I demonstrate an expression and purification scheme that utilizes 
the ATP-dependent G-Quadruplex resolving activity of G4R1 to selectively purify 
catalytically active recombinant G4R1 (rG4R1), combined with a traditional 
histidine-based purification method (ROUTH eta/. 2017). This method of 
purification will allow for advanced biochemical assays of rG4R1, particularly with 
regards to interactions between rG4R1 and different cellular structures. 
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1.2 Materials and Methods 
1.2.1 Preparation of G4-DNA Structures for rG4R1 Purification 
Formation of Biotinylated G4-DNA G-Quadruplex to be Used for the Purification 
of rG4R1 
To prepare G4-DNA structures for rG4R1 purification , the Z33-Bio 
oligomer was designed (Table 1). The 3' moiety of biotin is crucial for the 
purification protocol. Pellet 1 1Jmole of the oligomer using centrifugation and then 
resuspend the pellet in 250 IJL of water, for a final concentration of 4 mM Z33-
Bio. Add 25 IJL of G4 buffer (450 mM Tris-HCI , 25 mM EDTA, 2,500 mM NaCI, 
pH 8) to the solution and mix by pipetting. Then incubate the oligomer solution at 
50 ac for 48 hours. 
Oligomer Oligomer Sequences Names 
Z33-Bio 5' J AAA GTG ATG GTG GTG GGG GAA GGA TTC GGA CCT-Biotin 13' 
Z33-Aiexasao 5' I Alexa680-AAA GTG ATG GTG GTG GGG GAA GGA TTC GGA CCT 13' 
Table 1: Oligomer Sequences Used. These oltgomers are based off of Z33, a deoxyoltgonucleotlde prev1ously 
characterized to readily form tetramolecular G-quadruplexes (VAUGHN et at. 2005). 
After the incubation, collect condensation by spinning down the tube 
(1 ,000 ref, 10 seconds). Add 50 IJL of a high-mass, hydrophilic polysaccharide 
(30% Ficoll in H20) and mix by pipetting. 
Pour a 1 0% acrylamide/1 x Tris/Borate/EDTA (TBE) /1 0% glycerol gel (gel 
dimensions: 16 em x 16 em x 1 mm). After polymerization, wash the wells with 1x 
TBE and load the processed Z33-Bio oligomer evenly across most of the gel 
(sample lane loading can be visualized with Schlieren lines). In one lane, add a 
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small portion of the oligomer that has been heated at 98 oc for 1 0 minutes to 
serve as an unstructured control. Add gel loading dye to an empty lane to visually 
identify migration of sample through the gel. Using 1 x TBE, run the gel at 120 V 
until the loading dye has traversed approximately 1/3 of the gel. 
After running the gel , remove one of the glass plates and use ultraviolet 
(UV) shadowing on the gel (long wavelength: 365 nm) to visualize Z33-Bio 
bands. Using a clean , DNAse free razor, cut out the bands containing G-
Quadruplex-Z33-Bio, which will have run higher up on the gel than the non-
quadruplex bands. Place the gel containing the formed G-Quadruplexes in a 50 
mL tube and add soaking buffer (1/3 1 Ox TBE, 1/3 saturated sodium acetate pH 
8.8, and 1/3 molecular biology grade water) to cover the gel. Incubate the gel at 
37 oc overnight. 
Transfer the solution, without the gel , to a 15 mL tube and add 1.2x 
volume isopropanol and 1/10 volume glycogen (glycogen stock at 20 mg/mL in 
10 mM Tris-HCI pH 8, 2.5 mM EDTA, 0.05% sodium azide, and pH 8). Mix the 
solution by pipetting and then incubate the tube at -20 oc for at least 2 hours. 
Spin the tube at 2,700 ref in a tabletop centrifuge cooled to 4 oc for 12 min . 
Decant the supernatant solution and wash the pellet thrice with 50 mM NaCI in 
70% EtOH, repelleting the G-quadruplex by centrifugation as described above. 
Rehydrate the washed pellet by incubating at 4 oc for at least 2 hours. Then, 
resuspended the pellet in 50 ~L TNE buffer (1 0 mM Tris-HCI, 50 mM NaCI, 0.05 
mM EDTA, and pH 8) . Quantify the formed G-Quadruplex by adding 5 J,JL of this 
solution into 495 ~L of water and use a spectrophotometer that allows extinction 
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coefficient to be determined by entering an oligomer's nucleotide composition 
(the extinction coefficient of the Z33 DNA oligomer with a base composition of A 
= 8, C = 3, G = 15, and T = 7 is 341,946 Umol/cm). Use a dilution factor of 25 
(not 1 00), as the formed G-quadruplex consists of 4 strands of DNA. Aliquot the 
volume equivalent of 3 ODs (OD2so units) per tube and store at -20 ac; for 
example, if the 5 IJL that was added to the 495 IJL ofH20 gives an OD260 
reading of 3, then prepare 5 IJL aliquots. 
1.2.2 Preparation of G4-DNA Structures for rG4R1 Enzymatic Assays 
To prepare G4-DNA structures for rG4R1 enzymatic assay, the Z33-
Aiexa680 oligomer was designed (Table 1 ). 5' moiety for the Alexasao tag is 
crucial. 
Follow the same procedure as outlined for forming Z33-Bio G-
quadruplexes, but do not use UV shadowing, as the Z33-Aiexasao bands will be 
visible to the naked eye. After quantifying the Alexasao-labeled DNA G-
Quadruplex, dilute the G4-DNA to 0.2 pmoi/IJL with TNE buffer. Then, add 
glycerol to a 10% final concentration and store at -20 ac for further use. 
1.2.3 Production of rG4R1 in a Prokaryotic System 
Allow 20 IJL of (DE3) PlysS Competent bacteria to thaw on ice while 
warming 80 IJL of SOC medium (2% tryptone, 0.5% yeast extract, 10 mM NaCI, 
2.5 mM KCI, 10 mM MgCI2, 10 mM MgS04, and 20 mM glucose) at 37 ac. Once 
the bacteria have thawed, add 1 IJg of pTriEx4-DHX36 plasmid to the bacteria 
and swirl using a pipette tip to mix (VAUGHN eta/. 2005). After 5 minutes of 
incubating the bacteria and plasmid on ice, heat shock the cells at 42 ac for 30 
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seconds. Place the cells on ice for 2 minutes and then add 80 IJL pre-warmed of 
SOC medium. Shake the cells for 1 hour at 225 rpm and 37 octo allow for 
transformed cells to express their antibiotic resistance genes. Spread-plate the 
transformed bacteria on pre-warmed selection plates containing carbenicillin 
(GARB) and chloramphenicol (CAM) at 50 IJg/mL and 35 IJg/mL, respectively and 
incubate overnight at 37 oc. Inoculate 5 ml of LB media + GARB/CAM in a 
vented tube with one colony of bacteria from the agar plates (using a p1 000 
pipette tip), and then incubate the bacteria overnight at 37 oc , shaking at 225 
rpm. 
Add 1 ml of the liquid culture to 500 ml of Difco™ Terrific Broth (Thermo 
Fisher, MA, USA) with GARB/CAM in a large baffled flask. After sufficiently 
swirling the cultures for aeration, incubate the cells at 37 oc without shaking 
overnight. The next morning, begin shaking the cells at 225 rpm (while still at 37 
°C) until the 00600 is 0.4 - 0.6. Once the proper bacterial density has been 
reached, quickly cool the flask to 1 0 oc on ice. Once the media has reached 1 0 
oc , add IPTG to a 1 mM final concentration (120 mg I 500 ml culture) and 
incubate the cells at 14 oc while shaking at 80 rpm for 17 - 18 hours. After this, 
the bacterial concentration will ideally be at 0.8 - 1.2 00600. 
Transfer the bacteria to a 500 ml centrifuge tube and centrifuge the 
bacteria at 3,840 ref for 20 min at 4 oc. Decant the clarified broth and store the 
bacterial pellets at -80 oc until ready for protein purification. 
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1.2.4 Purification of Human rG4R1 
1.2.4.1 Thaw and Lyse Bacterial Pellets 
Thaw previously prepared bacterial pellets in 3 mL of TN buffer (1 00 mM 
Tris, 50 mM NaCI, pH 7.5) at room temperature. Once thawed and relatively 
evenly suspended, bring the volume up to 5 mL with TN buffer. Add lysis buffer 
(20 mg of lysozyme in 250 !JL water) to the resuspended bacteria, and then swirl 
the bottle in hand for 5 - 1 0 minutes while the lysozyme digests the bacteria. Add 
250 jJL of protease inhibitor cocktail (PIC) and 1 0 jJL leupeptin to the bottle, then 
mix thoroughly. Place the bottles on ice and add 10 mL of cold TN buffer and 22 
!JL ~-mercaptoethanol (BME) before transferring the solution to a 50 mL tube. 
In the 50 mL tube, sonicate the bacteria on ice with a digital Sonicator set 
to 30% amplitude with 2 second alternating on/off cycles for 1 minute (30 
seconds total sonication time). Repeat the sonication process for a total of 3 
times, with 2 minute breaks between each sonication step. 
Add 15 mL of cold 4x saline-sodium citrate (SSG) buffer, 20 !JL BME, 50 
!JL of PIC, and 1 0 !JL of leupeptin to the lysate and mix. After mixing, spin down 
the lysate in a pre-cooled 4 oc tabletop centrifuge at 23,000 ref for 20 minutes. 
Transfer the supernatant liquid to a new 50 mL tube on ice. 
1.2.4.2 Prepare G4-Magnetic Beads 
Add 1 mL of streptavidin paramagnetic bead (SPB) suspension to a 1.5 
mL microcentrifuge tube and pellet the beads with a magnet. After removing the 
supernatant liquid, wash twice with 2x SSG buffer+ 5 mM EDTA pH 8. 
Resuspend the SPB in another 200 !JL of SSG Buffer + EDTA. 
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Add one 3 OD aliquot of G4-Z33-Bio prepared previously to the SPB 
suspension and mix by pipetting. Place the microcentrifuge tube on a rotator and 
rotate at room temperature for 30- 60 minutes. After rotating, add 1 ml of 0.4% 
lactalbumin (diluted from 4% lactalbumin (in 2 M glycine pH 7.5 with 0.05% 
sodium azide and 1 x PIC) with 1 x Tris-glycine) to block the G4-bound SPB. 
1.2.4.3 Bind Histidine-tagged rG4R1 to Cobalt Beads 
Add 1 ml of cobalt bead (CB) slurry (0.5 ml bead volume) to the 50 ml 
tube of clarified bacterial lysate, and then incubate for 20 minutes at room 
temperature on a rotator. After rotating, pellet the CB at 110 ref for 5 minutes in a 
pre-cooled 4 oc tabletop centrifuge, and then aspirate the supernatant liquid, 
leaving - 2 ml of liquid to leave the pellet undisturbed. Wash the pellet with 10-
15 ml of cold 4x SSC + BME (0.5 !JL BME I ml of 4x SSC), but do not pipette 
the solution to mix. After spinning down the CB pellet, aspirate the liquid and add 
a second clarified lysate to the pelleted CB, followed by a 20-minute incubation 
on the rotator at room temperature. Wash the CB twice with 10-15 ml cold 4x 
SSC + BME, leaving - 2 ml of beads/supernatant liquid in the tube after the 
second wash. Use a "wide-bore" pipette tip (p1 000 pipette with end cut of by a 
fresh razor blade) to prevent shearing and transfer the CB to a pre-cooled 2 ml 
tube. Briefly centrifuge the CB at high speed ( - 18,000 ref) in a microcentrifuge at 
4 oc for 5 - 1 0 seconds. Gently remove as much supernatant solution as possible 
without disturbing the protein-bound CB. 
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1.2.4.4 Elute rG4R1 from Cobalt Beads 
Add 0.5 ml histidine elution buffer (HEB) (0.7 M L-histidine, pH 6) to the 
protein-bound CB without mixing and rotate for 5 minutes at 4 ac. Centrifuge at 
18,000 ref in 4 ac for 1 minute. Transfer the supernatant solution to a 15 ml tube 
kept on ice, being careful to leave some solution on top of the CB pellet. Repeat 
these HEB elution steps 2 more times for a total of 3 HEB elutions. 
Elute protein using 0.5 ml of 0.2 M EDTA pH 6.0 according to the steps 
above. Use a gel-loading tip on the end of a 1 ml pipette tip, plunged to the 
bottom of the CB tube, to obtain as much protein-containing elution buffer as 
possible. 
1.2.4.5 Bind rG4R1 to G4-bound SPB and Elute in an ATP-dependent 
Manner 
Prepare 5x Res buffer (250 mM Tris-Acetate pH 7.8, 250 mM NaCI, 2.5 
mM MgCI2 , and 50% glycerol) and 3x Res buffer (0.915 ml water, 2 ml 5x Res 
buffer, 0.33 ml 0.4% lactalbumin, 10 !JL BME, 15 !JL 1 M MgCI2 , 50 1-1L PIC, and 
10 !JL leupeptin). Pellet the prepared G4-SPB to the side of the tube with a 
magnet, discard the supernatant, and add 1 ml of 3x Res buffer, pipetting to mix. 
Add this G4-SPB solution to the 15 ml tube of HEB/EDTA eluate, then incubate 
for 15 minutes in a 37 ac water bath, occasionally agitating so the beads do not 
settle. 
On ice, pellet the protein-bound G4-SPB to the side of the tube with a 
magnet and remove the supernatant liquid. Wash twice with 1 ml of 4x SSG + 
0.4% lactalbumin+ 0.5 1-1UmL BME. During this step, ensure that all of the 
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magnetic beads have pelleted between washes. Wash the G4-SPB once with 1 
ml of 3x Res Buffer. 
Pre-warm 1 ml of elution buffer (EB) (0.5 ml 3x Res Buffer, 0.1 ml 0.1 M 
ATP, and 0.4 ml water) in PCR tubes in a heating block of a thermal cycler set to 
37 oc. Pellet G4-SPB with the magnet and suspend the beads in 1 00 IJL EB and 
immediately transfer the beads to a pre-warmed PCR tube, incubating at 37 oc 
for 30 seconds. Promptly add 12 IJL of 5 M NaCI and pipette vigorously 20-30 
times. During this step, minimize the formation of bubbles, as they can denature 
proteins. Immediately pellet the G4-SPB with a magnet and transfer the protein-
containing eluate to a fresh PCR tube on ice, then repeat the 1 00 IJL EB elution 
process again , producing -200 IJL of EB containing highly pure and catalytically 
active rG4R1. Set aside two 7 IJL aliquots for future enzymatic activity assays, 
and then store the purified rG4R1 at -80 oc. 
1.2.5 Quality Control Enzymatic Activity 
Prepare 300 IJL resolvase assay buffer (RAB) (0.1 ml 3x Res Buffer, 0.01 
ml 0.2 pmoi/IJL G4-Z33-Aiexasao, 0.03 ml 0.1 M ATP, and 0.16 ml water) and, 
in a strip of 6 PCR tubes on ice, pipette 40 !JL RAB into the first tube and 30 !JL 
RAB into every other tube. 
Retrieve a 7 IJL aliquot of rG4R1 , produced during the purification protocol 
above, and pipette up and down to mix the protein. Transfer 5 IJL rG4R1 to the 
first tube (already containing 40 IJL RAB). Serially transfer 10 IJL from the rG4R1-
RAB tube to the remaining PCR tubes containing RAB. Incubate this strip of PCR 
tubes for 30 minutes at 37 oc in a thermocycler, followed by a 4 oc hold. During 
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the hold, add 2 ~L of 0.5 M EDTA pH 8 to each tube (stopping enzymatic 
activity). 
Pour a 1 0% acrylamide/1 x TBE/1 0% glycerol gel (gel dimensions: 16 em x 
16 em x 1 mm). After polymerization, wash the wells with 1 x TBE. Add 5 IJL of 
30% Ficoll in H20 to each tube and load 15 ~L from each tube. As a control for 
G4-DNA mobility, add 4 ~L of 30% Ficoll in H20 to 20 ~L RAB and load 15 ~L. 
As a control for unwound monomeric Z33, head 20 ~L RAB at 98 oc for 1 0 
minutes, add ~L of 30% Ficoll in H20 , and load 15 ~L. Using 1 x TBE as a running 
buffer, run the gel at 120 V for -2 hours. Image the gel , looking for Alexa680 
bands. Highly active preparations of rG4R1 will yield complete resolution of 
Alexa580-labeled Z33 in the first lanes that were loaded on the gel, as shown in 
Figure 1. 
"C 
~ 
0 
.c 
G4-DNA 
Monomer DNA 
Figure 1: Quality-control rG4R1 Enzymatic Activity Assay. Lanes 1 - 6: A constant 
concentration ofT AMRA-labeled tetramolecu lar G4-DNA was incubated at 37 oc for 30 min in the 
presence of 4x serial dilutions of purified rG4R1 representing 3.9 iJL, 0.83 IJL, 0.2 iJL, 0.05 iJL, 
0.013 j.JL, and 0.003 j.JL, respectively. Lane 7: Tetramolecular G4-DNA in the absence of rG4R1. 
Lane 8: Tetramolecular G4-DNA boiled to reduce the G4 structure into monomers in the absence 
of rG4R1. 
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1.2.6 Pooling of Highly Active rG4R1 Preparations, Aliquoting, and Storage 
Calculate the total volume of rG4R1 that will be aliquoted (7 !JL is common 
for downstream assays) and fill the block of a thermal cycler set to 4 ac with 
strips of PCR tubes. Retrieve PCR tubes containing highly active preparations of 
rG4R1, thaw in hand, and place on ice when there is a small amount of ice 
remining in the tube. Combine all of these preparations into a pre-chilled 15 mL 
tube, mixing well while minimizing bubble formation. 
Use an automatic repeating pipette to dispense the desired aliquot volume 
into the pre-chilled PCR tubes in the thermal cycler. As soon as 1 - 2 strips are 
completed, a second person should close the lids and transfer the strips to 96-
well wafers floating in liquid nitrogen, in order to preserve enzymatic activity. 
After all of the strips have been flash-frozen, transfer the tubes from liquid 
nitrogen to dry ice, and then into a -80 ac freezer for long-term storage. 
1.2.7 Quantification of Purified rG4R1 
Pour a 5% stacking/12% resolving acrylamide/SDS gel for protein 
separation. Thaw -50 IJL of aliquoted rG4R1 , combine into one tube, and mix 
well. Confirm the exact volume with a pipette and add an equal amount of 2x 
Laemmli sample buffer (65.8 mM Tris-HCI, 26.3% (w/v) glycerol, 2.1% SDS, 
0.02% bromophenol blue, pH 6.8) + BME (50 1JU950 IJL of 2x Laemmli buffer). 
Denature the protein by incubating at 98 ac for 1 0 minutes. 
Prepare dilutions of broad range molecular weight markers in 1 x Laemmli 
buffer+ BME such that the following protein amounts can be loaded onto the gel 
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as standards: 31 .3, 62.5, 125, 250, and 500 ng. (Each protein standard 
contained in the broad-range MW markers is present at 0.1 IJg/IJL, except for the 
50 kDa protein , which is present at 0.3 IJg/IJL.) Wash the wells with 1 x 
SDS/glycine running buffer and add 50 IJL and 25 IJL denatured rG4R1 solution 
(25 and 12.5 IJL protein) . Load the protein standards prepared, being careful to 
be as precise as possible to ensure accurate quantification. Run the gel at 120 V 
until the dye has traversed - 2/3 of the gel. 
Remove the portion of the gel not containing any protein and place the 
protein-containing portion in a glass dish. Stain the gel with Coomassie dye (50 
mg of Coomassie R-250 per 100 ml of 50:10:40 v/v methanol:acetic acid:H20 
that has been filtered through a filter-paper funnel) overnight at room temperature 
on an orbital shaker to ensure adequate agitation of the gel. 
De-stain the gel with 30:10:60 v/v methanol:acetic acid:H20 , using balled 
up Kim Wipes rM (Kimberly-Clark, TX, USA) to expedite the de-staining process. 
During this process, the de-staining solution may need to be replaced. Continue 
de-staining until the background is low enough to visualize rG4R1 and the protein 
standards. A gel at this stage is shown in Figure 2. 
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Figure 2: Quantification of Purified rG4R1. Lanes 1 - 6: Broad-range molecular weight protein 
markers were loaded in these quantities: 500, 250, 125, 62.5, 31 .3, and 15.7 ng, respectively, 
and were used to generate a standard curve of protein concentrations. Lane 7: 35 ~L of rG4R1. 
This particular gel was quantified, as part of a triplicate set of gels, resulting in an average protein 
concentration of 62 ± 22 nM standard deviation (n = 9). 
Place the de-stained gel in a sheet protector and scan the gel at ~ 300 dpi 
resolution. Within an image analysis program, prepare standard curves from the 
protein standards that correspond to 75, 100, and 150 kDa (not including the 
background). From these standard curves, the concentration of rG4R1 can be 
interpolated. From the calculated concentration and known volume added, 
determine the mass of rG4R1 added. Then calculate the molar amount using 
rG4R1 's molecular weight (120,000 g/mol). This will produce 3 calculated molar 
values for rG4R1. Repeating this procedure 2 more times will produce 9 
estimates, which are then to be averaged into a single batch-specific rG4R 1 
concentration , typically in the range of 20- 100 nM. 
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1.3 Discussion 
This protocol demonstrates a highly efficient expression, purification, 
quantification, and enzymatic assay scheme for the isolation of G4R1, the protein 
product of DHX36. This protocol implements two purification steps: traditional 
His-tag affinity purification with cobalt beads and enzymatic purification with G4-
DNA-conjugated paramagnetic beads. The second purification process is key to 
the great potential of this purification. Exposing an already semi-pure eluate to 
G4-DNA-conjugated SPB will allow for the recovery of almost all rG4R1 proteins, 
due to their extremely high binding affinity for G-quadruplexes; almost all the 
impurities in the eluate without G-quadruplex affinities will be removed at this 
step, with non-specific G-Quadruplex binding proteins being washed off of the 
SPB. Then, the catalytic activity-based purification, adding in the necessary 
molecules (ATP and MgCI2) for rG4R1 to resolve G-Quadruplexes, allows for the 
elimination of any malfunctioning rG4R1 proteins that bind G-quadruplexes 
without possessing G-quadruplex resolving capabilities. The production of highly 
pure and exclusively catalytically active rG4R1 is a great tool for biochemical 
assays. This selectivity for catalytic activity separates this protocol from other 
protein purification methods, which are unable to separate enzymatically active 
proteins from enzymatically dead proteins (Boov eta/. 2015). 
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2.1 Introduction 
CHAPTER TWO 
G-Quadruplexes in C9orf72 ALS 
A recent breakthrough in the field of research for amyotrophic lateral 
sclerosis (ALS) was made when it was discovered that many patients suffering 
from ALS had a similar genetic mutation. This mutation is a hexanucleotide 
repeat expansion of the sequence GGGGCC within the gene C9orf72 (DEJESUS-
HERNANDEZ eta/. 2011; RENTON eta/. 2011 ). Within healthy individuals, this 
repeat expansion is repeated less than 30 times. People suffering from this 
variant of ALS typically have more than 30 copies of this guanine-rich sequence, 
with higher repeat numbers correlating with earlier onset and increased severity 
of the disease. Due to the high local concentration of guanine, this sequence has 
been found to form G-quadruplexes (DONNELLY eta/. 2013; HAEUSLER eta/. 
2014). 
G-quadruplex RNA sequences, forming due to the transcription of the 
repeat expansions, are commonly identified features of ALS and are considered 
to generate cellular toxicity by sequestering crucial RNA binding proteins 
(MIZIELINSKA eta/. 2013; REDDY eta/. 2013; ZU eta/. 2013; HAEUSLER eta/. 2014; 
CONLON eta/. 2016). Because the repeat expansion is 6 nucleotides long, the 
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expansion, when translated, creates a glycine/arginine dipeptide repeat that 
sequesters cellular proteasomes, inter1ering with protein degradation pathways 
(GuPTA eta/. 2017; Guo eta/. 2018). 
It has previously been shown that G4R1 is responsible for the majority of 
all G-quadruplex resolving activity in human cells (VAUGHN eta/. 2005; CREACY et 
a/. 2008). It is likely that G4R1 is functionally involved in ALS pathology because 
of G4R1 having the highest G-quadruplex binding affinity of any know G-
quadruplex binding protein, G4R1 having specificity for both DNA and RNA, 
allowing it to interact with the guanine-rich repeat expansion at multiple levels, 
and G4R1 has been found to associated with another ALS-Iinked protein, TDP-
43 (CREACY eta/. 2008; FREIBAUM eta/. 201 0; LATIMANN eta/. 201 0; GIRl eta/. 
2011; SMALDINO eta/. 2015). 
Furthermore, FUS, a protein known to cause ALS when mutated, 
possesses a G-quadruplex binding domain (TAKAHAMA eta/. 2015; CoPPEDE et 
a/. 2018). TDP-43, a protein known to associate with G4R1 and contribute to ALS 
when dysfunctional, utilizes RNA G-quadruplex affinity to transport mRNAs into 
neurites (FREIBAUM eta/. 201 0; ISHIGURO eta/. 2016). These intersections of ALS 
pathology and G-quadruplex biology outside of the C9orf72 repeat expansion 
might be due to a deeper entanglement of ALS with G-Quadruplexes. If so, 
G4R1, the foremost human G-quadruplex helicase, will likely be involved 
because of the reasons mentioned above. 
17 
2.2 C9 ALS Working Model 
Due to G4R1 's affinity for both DNA and RNA G-quadruplexes, there is 
great potential for G4R1 to be involved in ALS pathology at multiple levels. Our 
current working model for how G4R1 interacts with ALS pathology is that, initially, 
the guanine-rich expansion repeat will generate a high number of localized G-
quadruplexes. All of these G-quadruplexes would cause G4R1 proteins, with 
their particularly high quadruplex affinities, to bind the expansion repeat region. 
Normally, G-quadruplexes would prevent transcription by impeding the 
transcriptional machinery (Figure 3-A). However, the localization of G4R1 would 
allow for the unwinding of C9orf72, allowing for transcription to occur (Figure 3-
B). These transcripts, containing the guanine-rich expansion repeat, will have the 
same potential to form G-quadruplexes. However, there is the potential for there 
to be many more transcripts, possibly producing many G-quadruplexes in the cell 
that have the potential to sequester RNA binding proteins that are crucial to 
normal cellular function (Figure 3-C). However, the rapid abundance of G-
quadruplexes may trigger the cell to increase the expression of G4R1, which 
could cause problems in multiple ways. The G4R1 may localize to the original 
repeat expansion, allowing for even more transcription to occur, creating a 
positive feedback loop (Figure 3-D). Additionally, the expressed G4R1 may 
resolve the G-quadruplex RNA, allowing it to be translated (Figure 3-E). As 
mentioned above, this would produce dysfunctional proteins that would serve to 
hamper the cell's protein degradation system by inhibiting proteasome function 
(GUPTA eta/. 2017; Guo eta/. 2018). 
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A) G-Quadruplexes reduce RNA 
polymerase processivity 
G4Rl Unwinds G-Quadruplex 
B) structures, allowing transcription to 
proceed 
l 
C) RNA foci formation and sequestration of 
RNA binding proteins 
Presence of G-Quadruplexes 
D) upregulates G4Rl or other 
G-Quadruplex helicases 
) Translation of this RNA produces E malfunctioning proteins. 
Figure 3: Working Model of G4R1 's Involvement in ALS Pathology 
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2.3 Future Research 
Due to technical issues, we were unable to transfect Hela cells with 
plasm ids containing the C9orf72 expansion repeat. Once a protocol for 
transfecting Hela cells with these guanine rich plasmids is optimized, our lab will 
begin several experiments regarding G4R1. Chromatin immunoprecipitation 
(ChiP) will be used to verify an initial ChiP assay suggesting that G4R1 localizes 
to the expansion repeat localization. Due to G-quadruplexes inhibiting 
transcription and G4R1 knockdowns having been previously shown to decrease 
transcription of a guanine-rich gene, we hypothesize that knockdown of G4R1 
with siRNA will decrease transcription of the C9orf72 expansion repeat, thereby 
reducing C9 mANA and C9 RNA foci levels, which will be quantified by qPCR 
and RNA FISH, respectively. Utilizing plasmids with different repeat numbers in 
Hela cells, we will determine if greater expansion repeat size correlates with 
increased G4R1 levels with quantitative western blots. 
Due to TOP-43's known association with RNA G-quadruplexes, I propose 
that TOP-43's bound RNA sequences be identified by RNA immunoprecipitation 
(RIP). The usage of RIP allows for the quantification off TDP-43 bound to 
C9orf72 transcripts, relative to the number of repeat expansions. The benefit of 
this technique is that it can readily be transitioned to quantify the interactions 
between TDP-43 and G4R1 through co-immunoprecipitation (co-IP). 
The usage of co-IP would allow for the identification of possible 
interactions between FUS and G4R1. If these interactions are identified, it is 
possible that these will be due to the association of FUS with G-quadruplexes in 
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both DNA and RNA, so the usage of RIP and chromatin immunoprecipitation 
would identify if FUS was bound to C9orf72 or C9orf72 transcripts. 
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